Abstract
Effects of continuous pentobarbital administration on binding characteristics of [3H]MK-801 in the rat brain were examined by autoradiography. Animals were rendered tolerant to pentobarbital using i.c.v. infusion of pentobarbital (300μg/10μl/hr for 7 days) by osmotic minipumps and dependent by abrupt withdrawal from pentobarbital. The levels of [3H]MK-801 binding were elevated in rats 24-hr after withdrawal from pentobarbital while there were no changes except in septum and anterior ventral nuclei in tolerant rats. For assessing the role of NMDA receptor in barbiturate action, an NMDA receptor antagonist (MK-801, 2.7 femto g/10μl/hr) was co-infused with pentobarbital. The pentobarbital-infused group had a shorter duration of pentobarbital-induced loss of righting reflex (sleeping time) than that of the control group, and MK-801 alone did not affect the righting reflex. However, co-infusion of MK-801 blocked hyperthermia, and prolonged the onset of convulsions induced by t-butylbicyclophosphorothionate (TBPS) in pentobarbital withdrawal rats. In addition, elevated [35S]TBPS binding was significantly attenuated by co-infusion with MK-801. These results suggest the involvement of NMDA receptor up-regulation in pentobarbital withdrawal and that the development of dependence can be attenuated by the treatment of subtoxic dose of MK-801.
Similar content being viewed by others
REFERENCES
Nicoll, R. A. 1975. Pentobarbital: action on frog motoneurons. Brain Res. 96:119–123.
Macdonald, R. L., and Barker, J. L. 1978. Different actions of anticonvulsant and anesthetic barbiturates revealed by use of mammalian neurons. Science 200:775–777.
Higashi, H., and Nishi, S. 1982. Effects of barbiturates on the GABA receptor of cat primary afferent neurons. J Physiol. 332: 299–314.
Sawada, S., and Yamamoto, C. 1985. Blocking action of pentobarbital on receptors for excitatory amino acids in the guinea pig hippocampus. Exp. Brain Res. 59:226–231.
Teichberg, V., Tal, N., Goldberg, O., and Luini, A. 1984. Barbiturates, alcohols and the CNS excitatory neurotransmission: specific effects on the kainate and quisqualate receptors. Brain Res. 291:285–292.
Marszalec, W., and Narahashi, T. 1993. Use-dependent pentobarbital block of kainate and quisqualate currents. Brain Res. 608:7–15.
Morgan, W., Bermudez, J., and Chang, X. 1991. The relative potency of pentobarbital in suppressing the kainic acid-or the N-methyl-D-aspartic acid-induced enhancement of cGMP in cerebellar cells. Eur. J. Pharmacol. 204:335–338.
Collingridge, G. L., and Lester, R. A. J. 1989. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 41:143–210.
Grant, K. A., Valverius, P., Hudspith, M., and Tabakoff, B. 1990. Ethanol withdrawal seizures and the NMDA receptor complex. Eur. J. Pharmacol. 176:289–296.
Gulya, K., Grant, K. A., Valverius, P., Hoffman, P. L., and Tabakoff, B. 1991. Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res. 547:129–134.
Khanna, J. M., Wu, P. H., Weiner, J., and Kalant, H. 1991. NMDA antagonist inhibits rapid tolerance to ethanol. Brain Res Bull. 26:643–645.
Wu, P. H., Mihic, S. J., Liu, J. F., Le, A. D., and Kalant, H. 1993. Blockade of chronic tolerance to ethanol by the NMDA antagonist, MK-801. Eur. J. Pharmacol. 231:157–164.
McCaslin, P. P., and Morgan, W. W. 1988. Anticonvulsive activity of several excitatory amino acid antagonists against barbital withdrawal-induced spontaneous convulsions. Eur. J. Pharmacol. 147:381–386.
Short, K. R., and Tabakoff, B. 1993. Chronic barbiturate treatment increases NMDA receptors but decreases kainate receptors in mouse cortex. Eur. J. Pharmacol. 230:111–114.
Rabbani, M., Wright, J., Butterworth, A. R., Zhou, Q., and Little, H. J. 1994. Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence. Br. J. Pharmacol. 111:89–96.
Cooley, R. K., and Vanderwolf, C. H. 1990. Stereotaxic Surgery in the Rat: A Photographic Series (Kirby, Ontario).
Paxinos, G., and Watson, C. 1986. The rat brain in stereotaxic coordinates, 2nd edit. Academic Press, Orlando, Florida.
Kimura, T., Miyaoka, T., Saunders, P. A., Baker, M. L., Hume, A. S., Yamamoto, I., and Ho, I. K. 1993. Induction of tolerance to and physical dependence on pentobarbital continuous intracer-ebroventricular administration. J. Pharm. Exp. Ther. 266:1300–1305.
Flint, B. A., and Ho, I. K. 1980. Assessment of tolerance to and physical dependence on pentobarbital, induced by multiple pellet implantation. Eur. J. Pharmacol. 65:355–363.
Saunders, P. A., Kimura, T., Miyaoka, T., and Ho, I. K. 1992. Effects of pentobarbital tolerance and withdrawal on GABAA receptor antagonist binding. Life Sci. 50:1701–1709.
Burnham, W. M. 1985. Core mechanisms in generalized convulsions. Fed. Proc. 44:2442–2445.
Sakurai, S. Y., Penny, J. B., and Young, A. B. 1993. Regionally distinct N-methyl-D-aspartate receptors distinguished by quantitative autoradiography of [3H]MK-801 binding in rat brain. J. Neurochem. 60:1344–1353.
Edgar P. P., and Schwartz R. D. 1990. Localization and characterization of 35S-t-butylbicyclophosphorothionate binding in rat brain: An autoradiographic study. J. Neurosci. 10:603–612.
Jarvis, M. F., Murphy, D. E., and Williams, M. 1987. Quantitative autoradiographic localization of NMDA receptors in rat brain using [3H]PCP: comparison with [3H]TCP binding sites. Eur. J. Pharmacol. 141:149–152.
Wong, E. H. F., Kemp, J. A., Priestly, T., Knight, A. R., Woodruff, G. N., and Iversen, L. L. 1986. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA, 83:7104–7108.
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., and Seeburg, P. H. 1992. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science, 256:1217–1221.
Clinschmidt, B. V., Martin, G. E., Bunting, P. R., and Papp, N. L. 1982. Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Dev. Res. 2:135–145.
Olney, J. W., Price, M. T., Salles, K. S., Labruyere, J., and Frierdich, G. 1987. MK-801 powerfully protects against N-methyl-D-aspartate neurotoxicity. Eur. J. Pharmacol. 141:357–361.
Lehman-Masten, V. D., and Geyer, M. A. 1991. Spatial and temporal patterning distinguishes the locomotor activity effects of dizocilpine and phencyclidine in rats. Neuropharmacology 30:629–636.
Liljequist, S., Ossowska, K., Grabowska-Anden, M., and Anden, N. E. 1991. Effects of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur. J. Pharmacol. 195:55–61.
Loscher, W., and Honack, D. 1992. The behavioural effects of MK-801 in rats: Involvement of dopaminergic, serotonergic, and noradrenergic system. Eur. J. Pharmacol. 215:199–208.
Tricklebank, M. D., Singh, R. J., Oles, C., Preston, C., and Irversen, S. D. 1989. The behavioural effects of MK-801: A comparison with antagonists acting noncompetitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167:127–135.
Tseng, Y. T., Miyaoka, T., and Ho, I. K. 1993. Region-specific changes of GABAA receptors by tolerance to and dependence upon pentobarbital. Eur. J. Pharmacol. 236:23–30.
Tagashira, E., Izumi, T., and Yanaura, S. 1978. Experimental barbiturate dependence, I. Barbiturate dependence development in rats by drug-admixed food (DAF) method. Psychopharmacology 57:137–144.
Haefely, W., and Pole, P. 1986. Physiology of GABA enhancement by benzodiazapines and barbiturates, in Benzodiazapine/GABA Receptors and Chloride Channels: Structural and Functional Properties (Olsen R. W. and Venter, J. C., ed), pp. 195–207 Alan R. Liss, New York.
Turnbull, M. J., and Watkins, J. W. 1976. Acute tolerance to barbiturate in the rat. Eur. J. Pharmacol. 36:15–20.
Belknap, J. K., Ondrusek, G., Berg, J., and Waddingham, S. 1977. Barbiturate dependence in mice: Effects of continuous vs. discontinuous drug administration. Psychopharmacology 51:195–198.
Tabakoff, B., Yanai, J. and Ritzmann, R. F. 1978. Brain noradrenergic systems as a prerequisite for developing tolerance to barbiturates. Science 200:449–451.
Franklin, C. L. and Gruol, D. L. 1987. Acute ethanol alters the firing pattern and glutamate response of cerebellar Purkinje neurons in culture. Brain Res. 416:205–218.
Hoffman, P. L., Rabe, C. S., Moses, F., and Tabakoff, B. 1989. N-Methyl-D-aspartate receptors and ethanol: Inhibition of calcium flux and cyclic GMP production. J. Neurochem. 52:1937–1940.
Weight, F. F., Lovinger, D. M., White, G., and Peoples, R. W. 1991. Alcohol and anesthetic actions on excitatory amino acidactivated ion channels. Ann. NY Acad. Sci. 625:97–107.
Tabakoff, B., Rabe, C. S., and Hoffman, P. L. 1991. Selective effects of sedative/hypnotic drugs on excitatory amino acid receptors in brain. Ann. NY Acad. Sci. 625:488–495.
Pantazis, N. J., Dohrman, D. P., Luo, J., Thomas, J. D., Goodlett, C. R., and West, J. R. 1995. NMDA prevents alcohol-induced neuronal cell death of cerebellar granule cells in culture. Alcoh. Cli. Exp. Res. 19:846–853.
Engberg, G., and Hajos, M. 1992. Alcohol withdrawal reaction as a result of adaptive changes of excitatory amino acid receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:437–441.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oh, S., Hoshi, K. & Ho, I.K. Role of NMDA Receptors in Pentobarbital Tolerance/Dependence. Neurochem Res 22, 767–774 (1997). https://doi.org/10.1023/A:1022019423197
Issue Date:
DOI: https://doi.org/10.1023/A:1022019423197